Growth Metrics

Biogen (BIIB) Current Taxes (2016 - 2025)

Biogen has reported Current Taxes over the past 17 years, most recently at $114.8 million for Q4 2025.

  • Quarterly results put Current Taxes at $114.8 million for Q4 2025, down 79.06% from a year ago — trailing twelve months through Dec 2025 was $114.8 million (down 79.06% YoY), and the annual figure for FY2025 was $114.8 million, down 79.06%.
  • Current Taxes for Q4 2025 was $114.8 million at Biogen, up from $103.3 million in the prior quarter.
  • Over the last five years, Current Taxes for BIIB hit a ceiling of $626.1 million in Q1 2025 and a floor of $103.3 million in Q3 2025.
  • Median Current Taxes over the past 5 years was $240.6 million (2022), compared with a mean of $269.9 million.
  • Peak annual rise in Current Taxes hit 170.8% in 2025, while the deepest fall reached 79.3% in 2025.
  • Biogen's Current Taxes stood at $174.7 million in 2021, then skyrocketed by 48.77% to $259.9 million in 2022, then decreased by 0.96% to $257.4 million in 2023, then surged by 113.01% to $548.3 million in 2024, then plummeted by 79.06% to $114.8 million in 2025.
  • The last three reported values for Current Taxes were $114.8 million (Q4 2025), $103.3 million (Q3 2025), and $114.8 million (Q2 2025) per Business Quant data.